A CRISPR blog / bibliography
New developments in CRISPR technology, with a focus on mouse and human cell applications.
Tuesday, August 12, 2014
Seamless correction of beta-thalassemia mutations in iPSCs using #CRISPR and piggyBac transposon.
Efficient genome editing in human cells for therapeutic purposes will continue to be one of the most anticipated uses of CRISPR. Here's a new, good example of this direction, from Genome Research.
Seamless gene correction of β-thalassemia mutations inpatient-specific iPSCs using CRISPR/Cas9 and piggyBac.
Fei Xie, Lin Ye, Judy C. Chang, et al.
published online August 5, 2014
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)